Recent Finacing
Recent Raise
Aurealis Pharma is a biopharmaceutical company developing combination biologics that use food‑grade lactic acid bacteria to deliver multiple human therapeutic proteins for chronic non‑healing wounds (AUP‑16) and oncology (AUP‑5550).
